Cargando…

Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis

BACKGROUND: Patients receiving in-centre hemodialysis are at high risk of exposure to SARS-CoV-2 and death if infected. One dose of the BNT162b2 SARS-CoV-2 vaccine is efficacious in the general population, but responses in patients receiving hemodialysis are uncertain. METHODS: We obtained serial pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goupil, Rémi, Benlarbi, Mehdi, Beaubien-Souligny, William, Nadeau-Fredette, Annie-Claire, Chatterjee, Debashree, Goyette, Guillaume, Gunaratnam, Lakshman, Lamarche, Caroline, Tom, Alexander, Finzi, Andrés, Suri, Rita S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Joule Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177936/ https://www.ncbi.nlm.nih.gov/pubmed/33980499 http://dx.doi.org/10.1503/cmaj.210673

Ejemplares similares

CENtral blood pressure Targeting: a pragmatic RAndomized triaL in advanced Chronic Kidney Disease (CENTRAL-CKD): A Clinical Research Protocol
por: Goupil, Rémi, et al.
Publicado: (2023)

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4(+) T cell profile
por: Sannier, Gérémy, et al.
Publicado: (2023)

Infection control measures to prevent outbreaks of COVID-19 in Quebec hemodialysis units: a cross-sectional survey
por: Beaubien-Souligny, William, et al.
Publicado: (2021)

Accessing hemodialysis clinics during the COVID-19 pandemic
por: Beaudet, Matthew, et al.
Publicado: (2022)

An Unusual Initial Presentation of Lupus Nephritis as a Renal Mass
por: Goupil, Remi, et al.
Publicado: (2015)

Association of Glomerular Hyperfiltration and Cardiovascular Risk in Middle-Aged Healthy Individuals
por: Dupuis, Marie-Eve, et al.
Publicado: (2020)

Accuracy Difference of Noninvasive Blood Pressure Measurements by Sex and Height
por: Abbaoui, Yasmine, et al.
Publicado: (2022)

Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values
por: Bernier-Jean, Amélie, et al.
Publicado: (2017)

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
por: Chatterjee, Debashree, et al.
Publicado: (2022)

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
por: Nayrac, Manon, et al.
Publicado: (2021)

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
por: Attias, Philippe, et al.
Publicado: (2021)

Thinking Volume First: Developing a Multifaceted Systematic Approach to Volume Management in Hemodialysis
por: Blum, Daniel, et al.
Publicado: (2019)

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
por: Tauzin, Alexandra, et al.
Publicado: (2022)

A virtual ward for home hemodialysis patients – a pilot trial
por: Raphael, Michael J., et al.
Publicado: (2015)

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
por: Nayrac, Manon, et al.
Publicado: (2022)

Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
por: Miyazaki, Ryoichi, et al.
Publicado: (2023)

An Environmental Scan of Canadian Quality Metrics for Patients on In-Center Hemodialysis
por: Blum, Daniel, et al.
Publicado: (2020)

Prediction of Cardiovascular Events by Pulse Waveform Parameters: Analysis of CARTaGENE
por: Desbiens, Louis‐Charles, et al.
Publicado: (2022)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis
por: Labriola, Laura, et al.
Publicado: (2021)

Home Hemodialysis and Peritoneal Dialysis Patient and Technique Survival in Canada
por: Nadeau-Fredette, Annie-Claire, et al.
Publicado: (2020)

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
por: Tauzin, Alexandra, et al.
Publicado: (2021)

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study
por: Harvey, Benoît, et al.
Publicado: (2023)

Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients
por: Nacasch, Naomi, et al.
Publicado: (2022)

POS-939 EFFICACY OF BNT162b2 VACCINE IN PATIENTS UNDERGOING HEMODIALYSIS IN NORTH OF PORTUGAL
por: FRANCISCO, J., et al.
Publicado: (2022)

Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients
por: Takazono, Takahiro, et al.
Publicado: (2023)

Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients
por: Lessard, Myriam, et al.
Publicado: (2014)

Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients—A prospective observational study
por: Al‐Muhaiteeb, Abdullah, et al.
Publicado: (2022)

Immune Senescence Markers Predict the Cellular Immune Response to BNT162b2 Vaccination in Hemodialysis Patients
por: Van Praet, Jens T, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
por: Bensouna, Ilias, et al.
Publicado: (2022)

Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccine
por: Wu, Bryan, et al.
Publicado: (2022)

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine
por: Wasserstrum, Yishay, et al.
Publicado: (2022)

A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Predicting Outcomes in Acute Kidney Injury Survivors: Searching for the Crystal Ball
por: Beaubien-Souligny, William, et al.
Publicado: (2019)

Online Hemodiafiltration Compared to Conventional Hemodialysis in Critically Ill Patients
por: Piotte, Julie, et al.
Publicado: (2022)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis
por: Yau, Kevin, et al.
Publicado: (2021)

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Zitt, Emanuel, et al.
Publicado: (2021)

Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients
por: De Cagna, Maria Rosaria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h0865pslp9i61pp34dfhbo45in